145 related articles for article (PubMed ID: 9026748)
1. [Uterine fibromas and the hormonal pattern: the therapeutic considerations].
De Leo V; Morgante G
Minerva Ginecol; 1996 Dec; 48(12):533-8. PubMed ID: 9026748
[TBL] [Abstract][Full Text] [Related]
2. Sex steroidal regulation of uterine leiomyoma growth and apoptosis.
Maruo T; Ohara N; Wang J; Matsuo H
Hum Reprod Update; 2004; 10(3):207-20. PubMed ID: 15140868
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines.
Swartz CD; Afshari CA; Yu L; Hall KE; Dixon D
Mol Hum Reprod; 2005 Jun; 11(6):441-50. PubMed ID: 15879465
[TBL] [Abstract][Full Text] [Related]
4. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
5. Pathological evaluation of uterine leiomyomas treated with gonadotropin-releasing hormone agonist (GnRH-a) therapy: role of mast cells and a possible mechanism of GnRH-a resistance in leiomyomas.
Nakayama M; Mitsuhashi T; Shimizu Y; Ishihara O; Shimizu M
Pathol Int; 2008 May; 58(5):268-74. PubMed ID: 18429824
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells.
Ohara N; Morikawa A; Chen W; Wang J; DeManno DA; Chwalisz K; Maruo T
Reprod Sci; 2007 Dec; 14(8 Suppl):20-7. PubMed ID: 18089606
[TBL] [Abstract][Full Text] [Related]
7. [Directions of future research on GnGH analogs in the treatment of endometriosis and uterine fibromyoma].
Morini A; Aleandri V; Cantonetti G; Benagiano G
Minerva Ginecol; 1993 Oct; 45(10):455-65. PubMed ID: 8278076
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells.
Wang J; Ohara N; Takekida S; Xu Q; Maruo T
Hum Reprod; 2005 Jun; 20(6):1456-65. PubMed ID: 15760954
[TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for uterine leiomyoma: the role of hormonal modulation.
Cook JD; Walker CL
Semin Reprod Med; 2004 May; 22(2):105-11. PubMed ID: 15164305
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis and conservative therapy of uterine leiomyoma].
Mori T; Fujii S; Konishi I
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1144-9. PubMed ID: 3091738
[No Abstract] [Full Text] [Related]
11. [Estrogens and leiomyoma of the uterus].
Murakami T
Nihon Rinsho; 2006 Apr; 64 Suppl 4():364-9. PubMed ID: 16689335
[No Abstract] [Full Text] [Related]
12. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells.
Yamada T; Nakago S; Kurachi O; Wang J; Takekida S; Matsuo H; Maruo T
Hum Reprod; 2004 Apr; 19(4):815-21. PubMed ID: 15033949
[TBL] [Abstract][Full Text] [Related]
13. [Affect of insulin-like growth factor I and estradiol on the growth of uterine leiomyoma].
Huang J; Zou J; Xu B; Zhang Y; Chen X; Liu D
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):29-32. PubMed ID: 11938733
[TBL] [Abstract][Full Text] [Related]
14. Incidence, aetiology and epidemiology of uterine fibroids.
Okolo S
Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):571-88. PubMed ID: 18534913
[TBL] [Abstract][Full Text] [Related]
15. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma.
Gamage SD; Bischoff ED; Burroughs KD; Lamph WW; Gottardis MM; Walker CL; Fuchs-Young R
J Pharmacol Exp Ther; 2000 Nov; 295(2):677-81. PubMed ID: 11046105
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
18. [Cytoplasmic estrogen and progestin receptors in uterine myomatous tissue and serum estradiol and progesterone levels in women with uterine myoma].
Chen GA
Zhonghua Fu Chan Ke Za Zhi; 1984 Apr; 19(2):88-92. PubMed ID: 6468092
[No Abstract] [Full Text] [Related]
19. Factors in fibroid growth.
Andersen J
Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):225-43. PubMed ID: 10023420
[TBL] [Abstract][Full Text] [Related]
20. [Effects of mifepristone on gene expression of epidermal growth factor in human uterine leiomyoma].
Yang Y; Zheng S; Zhang Z
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):38-9. PubMed ID: 10682457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
